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Abstract: The present study aimed to investigate the effects of intestinal remote ischemic
preconditioning (iRIC) on ischemia-reperfusion injury (IRI) and gut barrier integrity in a rat model
of total hepatic ischemia (THI). Male Wistar rats (n = 50; 250–300 g) were randomly allocated
into two experimental groups: RIC/Control. Thirty minutes of THI was induced by clamping the
hepatoduodenal ligament. iRIC was applied as 4-min of ischemia followed by 11-min of reperfusion
by clamping the superior mesenteric artery. Animals were sacrificed at 1, 2, 6, 24 h post-reperfusion
(n = 5/group/timepoint). RIC of the gut significantly improved microcirculation of the ileum and
the liver. Tissue ATP-levels were higher following iRIC (Liver: 1.34 ± 0.12 vs. 0.97 ± 0.20 µmol/g,
p = 0.04) and hepatocellular injury was reduced significantly (ALT: 2409 ± 447 vs. 6613 ± 1117 IU/L,
p = 0.003). Systemic- and portal venous IL-6 and TNF-alpha levels were markedly lower following
iRIC, demonstrating a reduced inflammatory response. iRIC led to a structural and functional
preservation of the intestinal barrier. These results suggest that iRIC might confer a potent protection
against the detrimental effects of THI in rats via reducing IRI and systemic inflammatory responses
and at the same time by mitigating the dramatic consequences of severe intestinal congestion and
bacterial translocation.
Keywords: liver ischemia; total hepatic ischemia; ischemia; reperfusion; remote conditioning;
ischemic conditioning; intestinal conditioning
1. Introduction
Ischemia-reperfusion injury (IRI) is inevitably encountered in various clinical scenarios in liver
transplantation and oncological liver surgery, representing an important risk factor for inferior outcomes
with increased morbidity and mortality, prolonged intensive care/in-hospital stay, and a significant
increase of costs [1,2].
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Following a landmark observation of Toledo-Perayra et al., demonstrating the presence of
ischemic-reperfusion injury in transplanted livers of dogs in 1975, several methods have been
introduced to reduce hepatic IRI in experimental and clinical settings [1,3–7].
Remote ischemic conditioning (RIC) was introduced by Przyklenk et al. in 1993, showing for the
first time that brief ischemic-reperfusion attacks, applied at a remote organ or tissue (e.g., limbs or
intestine), can protect certain target organs against the deleterious effects of IRI via triggering various
protective pathways [8,9]. Although the RIC technique may be a powerful tool against the effects of
IRI in different experimental models and clinical scenarios, the exact underlying mechanisms and
the definitive explanation of the phenomenon still remain unclear [10]. Although, our group and
others have intensively investigated the effects of RIC applied on the skeletal muscle in partial hepatic
ischemia and liver transplantation [10–16], only very limited data is available on the effects of intestinal
RIC (iRIC) in total hepatic ischemia (THI) [17,18]. Longer periods of THI without porto-systemic shunt,
result not only in an expressed hepatocellular damage but also lead to a severe intestinal congestion and
injury of the small bowel mucosa with consequential loss of barrier function and bacterial translocation.
Therefore, prolonged periods of THI of over 30-min are considered to be lethal in rats, leading to high
mortality rates without intervention [17,19,20].
Due to this above-described dual injury (liver IRI and splanchnic congestion) induced by THI,
we hypothesized that iRIC might confer a protection via local conditioning effects on the small intestine,
protecting against the dramatic consequences of the loss of barrier function and bacterial translocation
as well as by mitigating hepatic IRI, targeting the liver as a remote organ.
This study was designed to investigate the effects of iRIC on hepatic and intestinal injury in a rat
model of THI. Various parameters, known to be relevant in IRI and RIC, were used to assess intestinal
and hepatic injury, systemic inflammation, and protective responses following THI and iRIC treatment.
2. Materials and Methods
2.1. Animals
All experiments were performed in accordance with institutional guidelines and the German
federal law regarding the protection of animals. The ethical proposal of the study was approved by the
responsible authorities (Bezirksregierung Köln, Cologne, Germany, ID: 50.203.2BN45). All animals
received human care according to the principles of the “Guide for the Care and Use of Laboratory
Animals” (8th Edition, NIH Publication, 2011, USA). The present study was designed, performed
and reported according to the principles of the ARRIVE (Animal Research: Reporting of In Vivo
Experiments) guidelines [21].
Male Wistar rats (RjHan:WI; Janvier Labs, Le Genest Saint Isle, France) were used (Σn = 50;
body weight range: 250–300 g). The animals were housed under specific pathogen-free conditions
according to the guidelines of the “Federation for Laboratory Animal Science Associations” (FELASA;
www.felasa.eu) with a 12-h light and dark cycle in a temperature- and humidity-controlled barrier
environment. Water and standard pellets for laboratory rats (Sniff GmbH, Soest, Germany) were
provided ad libitum.
2.2. Surgical Technique
To avoid disturbing effects of circadian rhythm, all experiments were performed at the same time
of day, following an acclimatization period of one week. Volatile anesthesia was performed using
2 vol% isoflurane (Forane; Abbott GmbH, Wiesbaden, Germany) during all the surgical interventions.
All surgical procedures were performed by the same surgeon.
After sufficient anesthesia and analgesia (buprenorphine 0.03 mg/kg/24 h; Temgesic; EssexPharma,
Haar, Germany), laparotomy was performed through a midline incision, the liver was mobilized
by cutting its ligaments and the superior mesenteric artery (SMA) was exposed. Remote ischemic
conditioning treatment was applied as 2 cycles of 4-min of ischemia and 11-min of reperfusion
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(total 30-min) by clamping of the SMA using an atraumatic microvascular clamp (Aesculap Yasargil
FT260T; B.Braun) as described by our group previously on different occasions (Figure 1) [11,13,14,17].
Animals of the Control group underwent the exact same procedure without iRIC. Afterwards, THI was
achieved by clamping the bilio-vascular pedicle of the whole liver using an atraumatic microvascular
clip (FT260T) and ensuring that both the main portal vein and the hepatic artery are included.
After 30-min of THI the clamp was removed to allow free reperfusion of the liver. No porto-systemic
shunt was applied. At the end of the surgical procedure, the laparotomy (in 1, 2, 6, 24 h of reperfusion
groups) was closed in two layers using 4-0 continuous sutures (Vicryl 4-0; Ethicon).
Postoperatively, the animals were placed in an intensive care unit cage (Vetario; Brinsea Products
Ltd., North Somerset, UK) for a recovery period of one hour, providing warmed air (30–35 ◦C) and
an oxygen supply. After surgery, antibiotic treatment and analgesia were achieved by subcutaneous
injections of cefuroxime sodium (16 mg/kg/24 h) (Cefuroxim Fresenius; Fresenius Kabi Deutschland
GmbH, Bad Homburg, Germany) and buprenorphine (0.03 mg/kg/24 h). During the first 4-h
postoperatively, animals were observed continuously and then transferred back to their cages and
normal environment. Following the observation periods defined by the protocol, samples were
collected, and animals were sacrificed subsequently under deep isoflurane anesthesia 2 vol%–4 vol%
and buprenorphine (0.03 mg/kg) analgesia.
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For the present study 50 surgical procedures were performed based on an a priori sample size 
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(Figure 1). 
Control: after dissection of the SMA and a corresponding sham waiting period of 30-min, no 
remote conditioning was applied and THI was induced as described above 
RIC: remote ischemic conditioning protocol was applied as described above before THI. 
Figure 1. Study flowchart surgical protocol. Animals were randomized into two experimental groups
(Control, RIC). Following laparotomy and dissection of the superior mesenteric artery (SMA) intestinal
remote ischemic conditioning (iRIC) was applied as of 4-min of ischemia and 11- in of reperfusion via
clamping of the SMA. Total hepatic ischemia was induced by clamping the hepatoduodenal ligament
including both the portal vein and the hepatic artery. Animals were sacrificed after 1, 2, 6, 24 h
of reperfusion for sample c llection and further analysis (n = 5/g oup/time point). Modified from
Emotzpohl, Czigany et al. Shock. 2018 [15]. Abbreviations used: iRIC—Intestinal remote ischemic
conditioning; SMA—Superior mesenteric artery.
2.3. Experimental Design
For the present study 50 surgical procedures were performed based on an a priori sample size
estimation. Recipients were randomly allocated into two experimental groups (n = 25 cases/group)
(Figure 1).
Control: after dissection of the SMA and a corresponding sham waiting period of 30-min,
no remote conditioning was applied and THI was induced as described above
RIC: remote ischemic conditioning protocol was applied as described above before THI.
After 1, 2, 6, and 24-h of portal reperfusion, liver and ileum microcirculation were measured in
anesthesia (n = 5 cases/group/time point). Systemic- and portal venous blood from the vena cava and
the portal vein as well as tissue samples from the liver (right mediate lobe) and from the ileum (2 cm
proximal from the ileocecal valve) were collected for analysis before the animals were sacrificed via
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exsanguination in deep anesthesia. Five animals per group have been used for the in vivo imaging
experiments. Figure 1. depicts a flowchart of the experimental protocol.
During the survival period all animals were visited at least every 12-h by an experienced veterinary
technician blinded for the experimental design and their clinical condition was evaluated using a
human-endpoints score sheet. The score sheet was based on the previous work of Morton and Griffiths
and the recommendations of our group for experimental studies in the field of liver research [21,22].
2.4. Liver and Ileum Perfusion
We evaluated hepatic and ileal microcirculatory perfusion using multiple timepoints at sacrifice,
before collecting blood and tissue samples. As a reference control (baseline), we measured hepatic
and ileal circulation in 10 rats just after laparotomy. The hepatic microcirculation (flow) and tissue
oxygen saturation (StO2) were evaluated using an O2C device and a corresponding surface probe
(O2C-oxygen to see device, LF1 surface probe; LEA Medizintechnik GmbH, Giessen, Germany) as
described by our team previously [11,15]. The output signal was transferred to an integrated computer
equipped with software to yield real-time display of data, and to record and analyze the blood flow
pattern and values (LEA Medizintechnik GmbH, Giessen, Germany).
2.5. Biochemical Analysis and Serum Cytokines
Blood samples, collected from the inferior vena cava and from the portal vein by direct puncture
with a 20-gauge needle at sacrifice, were centrifuged (room temperature, 10-min, 2500 rpm) and
then serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate
dehydrogenase (LDH) were measured using an automated analyzer and standard photometric
procedures (Vitros 250; Johnson and Johnson, Neuss, Germany). Serum samples, stored at −80 ◦C,
were used for interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) assessments using
commercial rat enzyme-linked immunosorbent assay (ELISA) kits (R and D Systems, Minneapolis,
MN, USA) according to the manufacturer’s guidelines.
2.6. Tissue Adenosine Triphosphate Concentration
The apical part of the left lateral lobe was snap-frozen with liquid nitrogen pre-cooled metal tongs
before sacrifice. Subsequently, the intestinal specimens were harvested from an identical anatomical
location without mesenteric tissue (1 cm segment of the ileum 2 cm proximal from the ileocecal valve)
and were immediately snap frozen in liquid nitrogen. Liver and intestinal tissues samples were stored
at −80 ◦C until the assessment of adenosine triphosphate (ATP) concentrations, as described in detail
elsewhere [11,23–26]. Briefly, the specimens were transferred into a vacuum freezer (Christ 2–16,
Osterode, Germany) at −40 ◦C with a pressure less than 0.001 atm for at least 2 weeks of freeze-drying.
After lyophilization, samples were homogenized and deproteinized and tissue ATP concentrations
were determined by standard enzymatic tests [24–26]. The results were calculated and expressed as
micromoles per gram of dry-weight.
2.7. Transmission Electron Microscopy
Following THI and 6-h of reperfusion, tissue samples of the ileum were immersed in a 2%
glutaraldehyde and paraformaldehyde solution in phosphate-buffered saline. Following further
sample preparation, as described before [27], specimens were examined using electron microscopy
(EM400 T/ST, Philips, Amsterdam, The Netherlands).
2.8. Bioluminescent Assessment of Bacterial Translocation
Before surgery, animals (n = 5/group) have received a standard dose of bioluminescent Escherichia
coli (E. coli), modified to contain the lux operon from P. luminescens, dissolved in phosphate-buffered
saline (6 × 1011 in 0.5 mL i.g.; orogastral administration using feeding needles). The lux genes code for
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both the bacterial luciferase and substrate biosynthesis enzymes, which enable the strain to produce
luciferase and its substrate simultaneously, thus no exogenous luciferin substrate was required [28].
Following surgery and 6 h of reperfusion the animals were re-anaesthetised and in vivo imaging
was performed using the IVIS 100 System (Caliper Life Sciences Inc., Hopkinton, MA, USA) as
described before [29–31]. Images were captured using the corresponding software provided by the
manufacturer (Living Image Software 2.0, Caliper Life Sciences Inc.). The imaging system consists
of a cooled charge-coupled-device camera mounted on a light-tight chamber, a camera controller,
a cryogenic refrigeration unit connected to a computer system. Following in vivo imaging, animals
have been sacrificed in deep anesthesia by removing the lungs, spleen, liver and mesenteric tissue
including lymph nodes and the presence of bioluminescence has been directly analyzed to assess the
translocation of labelled E. coli in distant organs following IRI.
2.9. Statistical Analysis
Results are expressed as mean ± standard error of the mean (s.e.m.) for each group. Two-way
analysis of variance (ANOVA) and Bonferroni post-hoc test was performed to analyze changes in
time dependent parameters and between group differences at each time point. Mann-Whitney-U test
was applied to test the differences within two groups. Differences were considered significant when
p < 0.05. Data plotting and analysis were performed using GraphPad Prism 8 (GraphPad Software
Inc., San Diego, CA, USA) software package.
3. Results
3.1. Liver and Ileum Microcirculation
The preischemic baseline hepatic and intestinal microcirculatory flow did not differ markedly
between the two experimental groups (Figure 2). During the period of iRIC, flow values of all
animals of the RIC group showed significant fluctuations which were more expressed in the ileal flow
(flow 10–140%).
During the ischemic period, no significant differences were detected between the groups. After liver
exclusion and the induction of THI, flow values of the liver and ileum have dropped dramatically.
Relatively rapid recovery of the flow was observed after the reperfusion period in the RIC group.
Over the early period of liver reperfusion flow values of both the liver and the ileum were significantly
higher compared to the Control group (Figure 2). Meanwhile, the iRIC treated animals have reached
flow-values comparable with the baseline values as early as after 2-h. Ileal and hepatic flow of the
Control group recovered only after 24-h leading to the loss of significance between the two groups
at this time point (Figure 2) Most prominent between group differences were registered after 6 h of
reperfusion (Ileum: RIC6hours vs. Control6hours, 132 ± 14 vs. 52 ± 14 %, p = 0.001; Liver: RIC6hours vs.
Control6hours, 102 ± 05 vs. 47 ± 13 %, p = 0.001; Figure 2).
Tissue StO2 of the liver and ileum showed similar characteristic features, however, StO2 values
did not follow the positive alterations of flow observed over the course of the reperfusion period in the
RIC group (Figure 2). Accordingly, no significant differences were found between the two experimental
groups, in terms of StO2 (Figure 2).
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Figure 2. Microcirculat on of the ileum and the liver. (A) Liver perfusion measured with the O2C device
remained higher in the RIC group compared t Control throughout the reperfusion period. (C) Ileum
perfusion remained higher in the RIC group compared to Control throughout the reperfusion period,
however the significant difference between the two experimental groups has disappeared after 24-h of
reperfusion. (B,D) Partially similar characteristic features were observed in terms of tissue oxygen
saturation of the liver and ileum over the course of the observation period, however, StO2 values did
not follow directly the positive alterations of the flow observed in the RIC group. Accordingly, no
significant between group differences were detected. (mean ± s.e.m, * p < 0.05, ** p < 0.01, *** p < 0.001,
RIC vs. Control, two-way ANOVA and Bonferroni post-hoc test, n = 5/group/time point). Baseline was
determined as the ean flow measured in 10 healthy animals right after lapar tomy. Abbreviations used:
iRIC—Intestinal remote ischemic conditioning; THI—Total hepatic ischemia, StO2—Oxygen saturation.
3.2. Biochemical Analysis and Serum Cytokines
Significant cellular injury has been characteri arkedly increased serum tr nsaminase
levels and LDH, showing a peak after 2-h of reperf sio (Figure 3). As it is characteristic following
30-min of THI in rats, both AST and ALT as well as LDH have increased dramatically in the Control
group, while the application of iRIC has led to a significantly reduced cellular injury (AST: RIC2hours vs.
Control2hours, 3217 ± 559 vs. 6145 ± 1025 IU/L, p = 0.004; ALT: RIC2hours vs. Control2hours, 2409 ± 447
vs. 6613 ± 1117 IU/L, p = 0.003; LDH: RIC2hours vs. Control2hours, 32,716 ± 1340 vs. 50,578 ± 10 877
IU/L, p = 0.03; Figure 3). After a maximal damage following 2-h of reperfusion, a reduction of serum
enzyme levels was observed in both groups during the later phase of reperfusion (Figure 3).
To be abl to differentiate between total serum cytokine concentrations and gut related cytokine
release, serum levels of TNFα and IL-6 hav be n measur d in both port l- and systemic samples.
No major differences were observed between the cytokine levels in these separate samples (Figure 4,
A vs. C and B vs. D). During the early phase following THI and liver reperfusion, serum levels of
TNFα and IL-6 have increased markedly in the animals of the Control group. In contrast to the Control,
iRIC resulted in a reduction of TNFα and IL-6 both in portal and systemic blood, leading to graphically
and statistically strongly significant difference between the treated and non-treated groups after 1 h
of reperfusion (Systemic TNFα: RIC1hour vs. Control1hour, 43.7 ± 3.4 vs. 78.7 ± 8.3 pg/mL, p = 0.001;
Systemic IL-6: RIC1hour vs. Control1hour, 177.6 ± 20.9 vs. 748.7 ± 333.5 pg/mL, p = 0.03; Figure 4).
However, as it was observed in the characteristics of the serum transaminases, the between group
differences have disappeared after 24-h of reperfusion (Figure 4).
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peak of injury after 2-h of reperfusion. The application of iRIC significantly reduced transaminase and
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AST—Aspartate aminotransferase; ALT—Alanine aminotransferase; LDH—Lactate dehydrogenase;
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ischemic conditioning.
3.3. Tissue Adenosine Triphosphate Concentration
Similar characteristic features were observed concerning liver and intestinal tissue ATP levels in
the RIC and Control groups (Figure 5). After a reduction of ATP levels following 1-h of reperfusion,
a substantial recovery of the tissue energy reserves was observed after 3-h. However, the RIC group
showed better preserved ATP levels throughout the experiments. There was a significant difference
between the RIC and Control groups after 1-h of reperfusion (Liver: RIC1hour vs. Control1hour,
1.34 ± 0.12 vs. 0.97 ± 0.20 µmol/g dry weight, p = 0.04; Ileum: RIC1hour vs. Control1hour, 1.97 ± 0.10 vs.
0.92 ± 0.23 µmol/g dry weight, p = 0.02; Figure 5). Despite some graphical differences, no significant
disparity was found between the RIC and Control groups after THI and 3-h of reperfusion (Figure 5).
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Figure 5. Liver tissue and il um ATP levels. RIC res lted in bett r preserved tissue ATP levels
throughout the observation period both in the liver (A) as well as in the ileum (B). Significantly higher
hepatic and intestinal ATP levels have been found in the RIC group vs. Control after 1-h of reperfusion.
(mean± s.e.m., * p < 0.05 RIC vs. Control, Mann-Whitney-U test, n = 5/group/time point). Abbreviations
used: RIC—Remote ischemic conditioning; ATP—Adenosine triphosphate.
3.4. Intestinal Barrie and Bacterial Transloca ion
Ultrastructural analysis of t e epithelial l yer of the ileum mucosa showed di rupted microvilli
which were partially showing signs of vacuolization as well as a disruption of the terminal web
and swollen mitochondria with partial disintegration of their cristae and membrane in the animals
of the Control group (Fi ure 6). Following the application of iRIC, much better preserved cellular
ultrastructure was observed on the samples of the RIC group with almost regular microvilli and
subcellular organelles (Figure 6).
Correlating w ll with the ultra t uctural changes assessed by electron microscopy, intestinal
barrier function was better preserved following iRIC and THI. Animals receiving bioluminescent
E. coli before IRI had a markedly increased extra-intestinal luciferase activity after 6-h of reperfusion,
especially in the liver and the lungs as well as in the mesenteric lymph nodes (Figure 6). No relevant
extra-intestinal activity was observed in the animals of the RIC group (Figure 6), suggesting the
presence of none or only a minor IRI related bacterial translocation.
J. Clin. Med. 2019, 8, 1546 9 of 16
J. Clin. Med. 2019, 8, x FOR PEER REVIEW  9 of 17 
 
 
Figure 6. Ultrastructural and functional assessment of intestinal barrier integrity. Following 
30-min of total hepatic ischemia and 6-h of reperfusion, electron microscopy of the ileum showed 
disruption of microvilli which were partially showing signs of vacuolization (arrows) as well as a 
disintegration of the terminal web (tw) and swollen mitochondria with partial disintegration of their 
membrane and cristae (asterix) in the animals of the Control group (A). Following iRIC, better 
preserved cellular ultrastructure was observed on the samples of the RIC group with almost regular 
microvilli and subcellular structures (B). To assess functional integrity of the intestinal barrier 
animals were treated with luciferase labelled Escherichia coli before THI (C). Following 30-min of 
ischemia and 6-h of reperfusion, bacterial translocation was assessed using an in vivo imaging 
system. After the retrieval of the organs these were assessed for luciferase intensity. Intestinal barrier 
function was better preserved following iRIC and THI. Animals receiving luciferase labelled E. coli 
before IRI had a markedly increased extra-intestinal luciferase activity after 6-h of reperfusion, 
especially in the liver and the lungs as well as in mesenterial lymph nodes in the Control group. No 
relevant extra-intestinal activity was observed in the animals of the RIC group. Abbreviations used: 
OM-original magnification; RIC-remote ischemic conditioning; THI-total hepatic ischemia; IVIS-in 
vivo imaging system; MLN-mesenterial lymph node. 
Figure 6. Ultrastructural and functional assessment of intestinal barrier integrity. Following 30-min
of total hepatic ischemia and 6-h of reperfusion, electron microscopy of the ileum showed disruption
of microvilli which were partially showing signs of vacuolization (arrows) as well as a disintegration
of the terminal web (tw) and swollen mitochondria with partial disintegration of their membrane
and cristae (asterix) in the animals of the Control group (A). Following iRIC, better preserved cellular
ultrastructure w obse ved on the samples of the RIC group with almost regular microvilli and
subcellular structures (B). To assess functional integrity of the intestinal barrier animals were treated
with luciferase labelled Escherichia coli before THI (C). Following 30-min of ischemia and 6-h of
reperfusion, bacterial tr nslocation was ssessed using an in vivo imaging system. After the retrieval of
the organs these were assessed for luciferase intensity. Intestinal barrier function was better preserved
following iRIC and THI. Animals receiving luciferase labelled E. coli before IRI had a markedly increased
extra-intestinal lucifera e activity after 6-h of reperfusion, especially in the liver and the lungs as well
as in mesenterial lymph nodes in the Control group. No relevant extra-intestinal activity was observed
in the animals of the RIC group. Abbreviations used: OM-original magnification; RIC-remote ischemic
conditioning; THI-total hepatic ischemia; IVIS-in vivo imaging system; MLN-mesenterial lymph node.
4. Discussion
The present study is one of the first and most comprehensive reports showing a dual protective
response triggered by iRIC in a rat model of THI. Our results demonstrate not only the prominent
effects of iRIC in mitigating remote hepatocellular damage but also a reduction of local damage of the
intestinal barrier induced by severe congestion and functional ischemia in a well-established rodent
model of THI. Ultimately, this complex dual protective response triggered by iRIC was manifested in
reduced systemic inflammation.
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The protective effects of RIC have been reported in IRI scenarios for a diversity of tissues and
organs in various experimental and clinical studies over the years [10,11,14–16,32–35]. However, only
scarce evidence is available from well-designed and comprehensive experimental studies which would
demonstrate the effects of intestinal RIC in total-or partial hepatic ischemia (Table 1). A previous study
of our group could show that iRIC can exert potent protection and reduce hepatocellular and intestinal
damage following THI via a HO-1 mediated pathway in the second window of protection (using a
48-h recovery period between iRIC and THI) [17]. Here we aimed to assess the acute or so-called
“first window” effects of iRIC on hepatocellular injury and intestinal barrier integrity in THI.
Table 1. Studies with intestinal remote ischemic conditioning in liver ischemia.
Author Species andStrain Model
Sample








2 × 4 min of ischemia and
11 min of reperfusion by
clamping the SMA
directly before THI
1, 2, 6, 24 h
iRIC is a feasible technique








preconditioning, 2 × 4
min of ischemia and 11
min of reperfusion by
clamping the SMA 48 h
before THI
2, 6, 24, 240 h
iRIC remarkably attenuates
hepatic IRI in the second
window of protection after
48-h, presumably by HO-1
induction in hepatocytes









2 × 10 min of ischemia
and 10 min of reperfusion




against hepatic IRI by
modulating apoptosis and
inflammation.
Literature search (PubMed; search date: 10 September 2019; search terms: ischemic preconditioning OR ischemic
conditioning AND intestine AND liver) resulted in two relevant studies on iRIC in liver ischemia, showing very
limited evidence available on the effects of iRIC in THI. According to the best of our knowledge, the present study is
one of the most comprehensive experimental works so far on iRIC and its effects in liver IRI. Abbreviations used:
THI—Total hepatic ischemia; RIC—Remote ischemic conditioning, IRI—Ischemia reperfusion injury; SMA—Superior
mesenteric artery.
As the hepatic vascular bed is located just downstream of the small intestine collecting the portal
blood, complete inflow occlusion of the liver without porto-systemic shunt results not only in ischemic
liver injury but in severe congestion of the splanchnic organs resulting in functional ischemia of the
gut [17]. In this model, the combination of a hepatic IRI and severe intestinal congestion, with structural
and functional damage of the intestinal barrier and consequential bacterial translocation, are leading to
a systemic proinflammatory activation [17,36]. We hypothesize that the benefit of iRIC in the scenario
of THI, compared to the more widely used and reported RIC of the limbs, lies in the combination of a
“local conditioning” on the intestine which may protect against the detrimental intestinal congestion
and a “remote conditioning” effect targeting the liver.
Impairment of tissue microcirculation is one of the key elements in IRI [10,11,37]. A combination
of different mechanisms is contributing to a post-ischemic microcirculatory failure such as endothelial
neutrophil stasis, cell swelling, sludges and formation of micro-thromboses in small capillaries and liver
sinusoids [11,37]. In the present study we registered hepatic and intestinal microcirculation using the
laser Doppler based O2C system. Remote conditioning resulted in better preserved microcirculation of
the liver and the gut, especially during the early phase of liver reperfusion, however, the significant
difference on the level of microcirculation disappeared after 24-h of reperfusion. Microcirculatory failure
is not only a consequence of IRI but it also actively contributes to the paradox damage documented
as reperfusion injury by maintaining an impaired perfusion at the level of the small capillaries and
sinusoids and aggravating tissue injury [37]. Positive effects of RIC on target organ circulation were
confirmed in various IRI models [11,13–15,38,39]. In previous reports, we could demonstrate that
RIC applied on the infrarenal aorta is able to potently improve graft macro- and micro-circulation
including post-reperfusion microcirculatory flow and portal venous flow in a rat model of orthotopic
liver transplantation as well as in 70% partial liver ischemia and liver resection [11,13–15].
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A sublethal period of 30-min THI in rats without porto-systemic shunt leads to a severe
hepatocellular damage, characterized by a prominent elevation of serum transaminases [40]. In our
study the peak of hepatocellular injury was observed 2-h following liver reperfusion with strongly
increased AST, ALT and LDH levels. The potent ability of iRIC to mitigate hepatocellular injury was
characterized by significantly reduced transaminases and LDH in the RIC group compared to the
non-treated animals. These findings are in line with our previous reports with limb RIC and partial
liver ischemia [13,14] or liver transplantation [11,15] as well as correlates with our findings with iRIC
and THI showing similar effects in the second window of protection after 48-h [17].
A rapid drop of tissue ATP content during THI results in disturbed active ion transport
mechanisms, contributing to cellular swelling, microcirculatory failure and cell death [11,37,41].
A “reconditioning” effect, leading to better preserved or increased ATP production is associated with
improved mitochondrial and cellular integrity following RIC and ischemia (via the prevention of
mitochondrial permeability transition pore opening, less mitochondrial oxidative stress, reduction of
calcium overload) [42,43]. Therefore, increased levels of tissue ATP may be interpreted as a global
manifestation of better preserved mitochondrial and cellular functions. Previous reports could show
the beneficial effects of different ischemic conditioning approaches and pharmacological agents on
tissue energetic status and ATP levels [11,44,45]. Our data show favorable alterations in hepatic and
intestinal tissue ATP levels during reperfusion and iRIC. After 1-h of reperfusion significantly higher
ATP levels were found in the RIC group vs. Control.
There is a plethora of experimental and clinical evidence showing that imbalance in systemic
pro- and anti-inflammatory processes likewise belongs to the main events in the pathophysiology of
liver IRI [11,46]. An inflammatory cytokine release, associated with intestinal congestion and ischemia
as well as bacterial translocation further aggravate systemic and remote organ damage leading to
inferior outcomes [47,48]. In previous reports we could show that RIC of the limbs results in the
upregulation and downregulation of anti- and pro-inflammatory cytokines (including Interleukin-10,
Monocyte chemoattractant protein-1, Macrophage Migration Inhibitory factor, and TNFα) in models of
orthotopic liver transplantation or partial liver ischemia [11,14,15]. In line with these previous findings,
our present results show significantly reduced levels of TNFα and IL-6 in portal- and systemic blood,
suggesting a greatly reduced systemic inflammation following the application of iRIC in this severe
model of THI. The comparable levels of both cytokines observed in the portal- and systemic circulation
indicates that the gut is the major source of these cytokines [36].
However, a significant elevation in the serum levels of inflammatory cytokines is not only
a sign of increased tissue damage and systemic inflammation, but these cytokines also actively
participate in aggravating local tissue injury induced by THI [36]. The increase in translocation of
bacterial products to the gut-associated lymphatic tissue following hypoxia/ischemia of the intestinal
wall tissue triggers an orchestra of pro-/anti-inflammatory cytokine release [36,49,50]. Among these
inflammatory mediators, TNFα has received an intense scientific interest because of its role in increasing
tight-junction (TJ)-permeability in the intestine not only through a decreased expression of TJ proteins
but via the activation of myosin light chain kinases, leading to a disruption of barrier function [36,49].
Therefore, enhanced TNFα levels appears to play a central role in promoting pathological bacterial
translocation [36].
Other cytokines such as IL-6 and Interferon-gamma have been shown to increase intestinal
epithelial permeability and induce translocation of E. coli across epithelial cells [36,51]. Accordingly,
we have observed a relevant ultrastructural damage of the epithelial cells of the ileum following
30-min of THI and 6-h of reperfusion in our present model, including a disruption of the microvilli,
disintegration of the terminal web structure and swollen mitochondria with partial disintegration.
Following iRIC these pathological alterations were largely mitigated with an overall better preserved
cellular ultrastructure.
These structural observation correlated well with the observed damage of the functional barrier.
Following the administration of bioluminescence E. coli, significant extra-intestinal accumulation was
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observed in the animals of the Control group, while no relevant luciferase activity was detected by the
IVIS system in the animals of the RIC group, suggesting an active reduction of bacterial translocation by
iRIC. Only very limited data is available to date on the effects of iRIC on barrier integrity and bacterial
translocation following liver IRI (Table 1). In our previous report by Kageyama et al., we could show a
reduced mucosal damage in the second window of protection following iRIC assessed by the Park
score on conventional histological samples [17]. This was associated with an increased expression of
hemoxygenase-1 (HO-1) in the intestinal mucosa and in the liver, suggesting a potential mechanistic
role of HO-1 behind the effects of late iRIC [17].
As the presents study did not aim to compare different iRIC protocols concerning the length and
numbers of cycles, it is not possible to draw a conclusion, whether there are alternative iRIC protocols
potentially triggering an even superior protective response. Despite the many reports attempting to
find the optimal RIC protocol, a widely accepted guideline is still not within reach and the selection of
the protocols is mostly based on empiric choices [10,52,53]. Due to the lack of an optimal RIC protocol
some authors have also expressed their concern about a potential “hyperconditioning” phenomenon,
where excessive or repetitive stimulus may lead to a deleterious effect [52,54]. While the skeletal muscle
of the extremities (where RIC is conventionally applied) has a high ischemic tolerance, the small bowel
mucosa is notoriously sensitive for hypoxia and ischemia [10,11,14,15]. Therefore, in the present study
we aimed to use a less intense protocol with shorter total ischemia times (8 min in total) to minimize
the ischemic insult of the small bowel but maximize the potential benefits.
The findings of our study have to be interpreted in the light of certain limitations. This study is
one of the first reports on iRIC in THI (Table 1). Therefore, in this preliminary setting we were not
able to perform a deep exploration of the subcellular mechanisms behind the observed protective
effects of iRIC, thus our findings remain partially descriptive. The further inclusion of an “iRIC only”
(an experimental group receiving iRIC treatment without THI) and sham laparotomy groups may
have strengthened the statistical analysis and the conclusions of the study, resulting in a more solid
overall message.
Notwithstanding the aforementioned limitations, the present study shows some novel findings on
the dual way of protection conferred by iRIC in a well-established model of THI without porto-systemic
shunt. iRIC seemed to be a feasible technique which could potently reduce hepatocellular injury,
improve intestinal and hepatic microcirculation, positively influenced inflammatory cytokine and
tissue ATP levels and mitigated a consequential disintegration of the intestinal barrier and prevented
bacterial translocation (Figure 7). More detailed exploration of the mechanistic steps behind these
observations and identification of the connecting pathways between the gut and the liver following
iRIC and THI would be of interest for future basic and translational research.
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Figure 7. Summary of the mechanism and effects of iRIC observed in the setting of THI in rats.
The following flowchart depicts the observed an possibl protective eff cts and mechanisms of action
of iRIC following THI in rats. Briefly, iRIC applied as short periods of ischemia-reperfusion before THI
at a remote organ (intestine) results in the transfer of protective signals via different humoral and/or
neural and partially unknown connectiv mechanisms to the target organ (liver), however, it seemingly
also confers a local protection against the detrimental effects of intestinal congestion and functional
ischemia of the gut, via preserving the integrity of the intestinal tissue and barrier function and resulting
in less dramatic systemic effects of THl. Adapted from Emotzpohl, Czigany et al. Shock. 2018 [15].
Abbreviations used: iRIC—Intestinal remote ischemic conditioning; THI—Total hepatic ischemia.
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